Home › Funds › Avoro Capital Advisors LLC › DMRA
Avoro Capital Advisors LLC position in DMRA
DAMORA THERAPEUTICS INC · Health Care
Avoro Capital Advisors LLC reported holding 3,783,000 shares of DMRA (DAMORA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$80.5M, representing 0.83% of its reported portfolio and ranking #18 among its reported holdings. Avoro Capital Advisors LLC has disclosed DMRA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Avoro Capital Advisors LLC's DMRA position evolved
Avoro Capital Advisors LLC first disclosed a stake in DMRA in Q1 2026 at 3,783,000 shares (US$98.0M). The position peaked in Q2 2026 at 3,783,000 shares, worth US$98.4M. Across 3 filings, Avoro Capital Advisors LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 3,783,000 shares valued at US$80.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 3.78M | $97.98M | New |
| Q2 2026 | 3.78M | $98.40M | Hold |
| Q3 2026 | 3.78M | $80.50M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DMRA and 13F data
DMRA (DAMORA THERAPEUTICS INC) is a Health Care company. 91 other funds we track also report a position in DMRA — the largest reported positions include Fairmount Funds Management LLC (US$226.6M), Venrock Adviser, LLC (US$93.7M), RA CAPITAL MANAGEMENT, L.P. (US$62.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DMRA
- Fairmount Funds Management LLC 8.71M sh · $226.63M · Q2 2026
- Venrock Adviser, LLC 3.60M sh · $93.73M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 2.40M sh · $62.42M · Q2 2026
- FCPM III SERVICES B.V. 2.44M sh · $51.94M · Q3 2026
- Commodore Capital LP 1.94M sh · $50.43M · Q2 2026
- Remedium Capital Partners, LLC 2.05M sh · $43.53M · Q3 2026
- BRAIDWELL LP 1.62M sh · $42.15M · Q2 2026
- Bellevue Group AG 1.62M sh · $42.11M · Q2 2026
- a16z Capital Management, L.L.C. 1.24M sh · $32.15M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.22M sh · $31.81M · Q2 2026
- Cormorant Asset Management, LP 1.00M sh · $26.01M · Q2 2026
- Siren, L.L.C. 900.00K sh · $19.15M · Q3 2026
More on Avoro Capital Advisors LLC
FAQ
How long has Avoro Capital Advisors LLC held DMRA?
Avoro Capital Advisors LLC has disclosed DMRA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Avoro Capital Advisors LLC's current position in DMRA?
As of Q3 2026, Avoro Capital Advisors LLC holds 3.78M shares of DMRA (DAMORA THERAPEUTICS INC), valued at $80.50M, representing 0.83% of its reported portfolio and ranking #18.
Has Avoro Capital Advisors LLC been buying or selling DMRA?
In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC held unchanged its position in DMRA. The position peaked in Q2 2026 at 3.78M shares.
Which other funds hold DMRA?
Other major institutional holders of DMRA include Fairmount Funds Management LLC, Venrock Adviser, LLC, RA CAPITAL MANAGEMENT, L.P., among 91 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.